Repealing the HMO Act is not on any politician’s agenda. But perhaps a better regulated, less heavily profit-oriented system of multiple payers could work in the U.S.
Repealing the HMO Act is not on any politician’s agenda. But perhaps a better regulated, less heavily profit-oriented system of multiple payers could work in the U.S.
Same desk, different stories
Bloomberg's Ryan Gould joins Dani Burger on Bloomberg Deals. Activist investor Irenic Capital Management has built a position in social media company Snap and is pushing for changes to improve financial and operating…
Agrivoltaics is 3X more efficient land use than ethanol. Agrivoltaics keeps farm jobs, grows more food and provides plenty of juice for our EVs.
Applied Materials shares look set to continue to benefit from recent chip-sector strength, while Broadcom’s stock should rebound as AI-chip revenue grows.
As promised, Apple has released a new iPhone update aimed at protecting users against a specific risk.
Funding for the Department of Homeland Security — including the TSA — lapsed in February, over Democratic concerns about the agency's immigration enforcement.
Bloomberg's Michelle Davis joins Dani Burger on Bloomberg Deals. Biogen has agreed to acquire Apellis Pharmaceuticals for $5.6 billion, expanding its treatments in immunology and rare diseases in one of the company’s…